<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> is the third most common malignant disease in incidence according to a report in 2009 from Korea </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi> (5-FU) remains to be a major chemotherapeutic agents </plain></SENT>
<SENT sid="2" pm="."><plain>But, over the last 10-15 years, the treatment pattern for <z:e sem="disease" ids="C0948380" disease_type="Neoplastic Process" abbrv="">metastatic colorectal cancer</z:e> changed significantly </plain></SENT>
<SENT sid="3" pm="."><plain>Irinotecan and <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> are cytotoxic drugs, or bevacizumab and cetuximab are monoclonal antibodies against molecular targets </plain></SENT>
<SENT sid="4" pm="."><plain>The introduction of novel agents targeting specific molecular features of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells promises more options and marked improvements in efficacy for the treatment of metastatic <z:hpo ids='HP_0003003'>colon cancer</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Bevacizumab has been shown to extend survival in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> when used in combination with irinotecan and 5-FU-based chemotherapy, and the addition of cetuximab to irinotecan and 5-FU-based chemotherapy eliminates irinotecan resistance </plain></SENT>
<SENT sid="6" pm="."><plain>Better understanding of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> biology and the molecular pathway and mechanisms of <z:mp ids='MP_0002006'>tumorigenesis</z:mp> has led to the discovery of novel agents with improved outcomes </plain></SENT>
<SENT sid="7" pm="."><plain>(Korean J Gastroenterol 2013;61:128-135) </plain></SENT>
</text></document>